|
|
Current Trends in Corporate Social Responsibility in the Pharmaceutical Industry
Berezovskaya, Maria ; Cook, Gina (advisor) ; Lhotáková, Markéta (referee)
Abstract: The main purpose of this academic work is to study how Corporate Social Responsibility (CSR) is incorporated in companies in pharmaceutical industry, with emphasis on the interaction between the enterprise and the community. The goal is to understand what benefits may this collaboration bring in the long-term. In order to fulfil these objectives, a study case was built based on GlaxoSmithKline Plc., which has been using these practices and has a valuable impact in the countries it is present in. The study insists on the necessity of seeing CSR as a part of any successful business strategy involving all members of the value chain. Patient is the one who benefits the most from CSR activities in pharmaceutical industry, and patient is the one who pays and talks.
|
|
|
Evaluation of company GlaxoSmithKline s.r.o.
Mádle, Jakub ; Scholleová, Hana (advisor) ; Štamfestová, Petra (referee)
As a goal of my thesis a have desided to evaluate company GlaxoSmithKline sro. Firstly, I conducted a strategic analysis in which I focused on the macro and micro environment. Then I continued with a financial analysis of the company, during which I apllied the horizontal, vertical and ratio analysis. That showed that company management is fine and it is possible to determine the value of the company. To confirm this fact, I applied bankruptcy and credibility models. Then I continued with the evaluation of the company for which I used a two-stage DFC entity method. The result was subsequently supplemented by a sensitivity analysis and alternative assessment company using the book value.
|
|
| |
|
|
Prescription dose
JEŽKOVÁ, Jana
This work deals with the problematic of development of pharmaceutical containers with regards to history and typology of shape. Based on theoretical work a realization of a new type of container, made of ceramic cast material, has been created.
|
|
| |
|
|
Bank financing of pharmaceutical company
Drexlerová, Hana ; Půlpánová, Stanislava (advisor) ; Burešová, Jana (referee)
The aim of my thesis is to propose a financing structure for the selected company and then process the credit application. The first part is focused on the strategy of the bank, lending products and the risks that the bank undertakes. Also contains a description of the credit process - the calculation of a credit rating, financing structuring, collateral, covenants determination and processing of credit application. The thesis analyses the specifics of the pharmaceutical industry. Theoretical knowledge is applied to the example of financing of pharmaceutical company and the preparation of a credit application.
|
|
|
The Trade-Related Aspects of Patent Protection in Pharmaceuticals in Selected Asian Economies
Trojanová, Kamila ; Štěrbová, Ludmila (advisor) ; Zamykalová, Miroslava (referee)
The purpose of my thesis is to analyse and compare trade-related aspects of patent protection in pharmaceuticals in China and India. The first chapter addresses the basic economic and legal models devoted to the impacts of intellectual property rights on the pharmaceutical industry in both developed and developing countries. The second chapter describes the development of patent protection in pharmaceuticals in China and in India. The Chapter Three focuses on a comparison of roles and patent strategies of research oriented and generic pharmaceutical companies on the Chinese and Indian markets. The fourth chapter is devoted to the issue of access to medicines in developing countries with emphasis on the role of China and India. Conclusions are drawn in the closing part which focuses on the summary of current issues.
|
|
|
Lobbying in the USA – The analysis of lobbying spending
Hazalová, Jana ; Vymětal, Petr (advisor) ; Müller, Karel (referee)
Lobbying spending is a current and often discussed topic in the United States. Despite plenty of publications about lobbying only few of them deal with lobbying spending. Those are the essential reasons for choosing this topic. This work focuses on complex analyses of lobbying spending and attempts to answer three questions: who are the top spenders, how much do they spend on lobbying and on which purpose between the period 2001 and 2011. The text is divided into three chapters. The first chapter deals with lobbying definition, its history in the USA and the current legislation. The second chapter analyses top industries and top lobbying spenders. The third chapter discusses the spending of pharmaceutical industry. Both last chapters have the same structure. At first, the particular subjects and overall spending are presented. The next part analyses development of spending and the aim of their use.
|
|
|
Marketing Communication in Pharmaceutical Industry: GS CONDRO FORTE
Frýdlová, Jana ; Lešetický, Ondřej (advisor) ; Jankůj, Miroslav (referee)
The aim of this thesis is to present the theoretical attributes of marketing communications, as part of the marketing mix and in particular in relation to specific areas of the pharmaceutical industry. The practical part is focused on pharmaceutical product marketing communication towards the ultimate consumer. For this goal I chose Green pharmaceutical company - Swan Pharmaceuticals CR, as a nutritional supplement for her joints Condro Forte GS.
|
|
|
Effects of Intellectual Property Rights Protection on Access to Medicines in Subsaharan Africa
Nemkyová, Renata ; Šaroch, Stanislav (advisor) ; Bič, Josef (referee)
The aim of the text is to defend a thesis: "A uniform and strict regime of intellectual property rights (IPR) protection for all member states of the World Trade Organization harms the less developed ones." The text also pursues the problems strong protection of IPR can cause to developing countries in the area of access to pharmaceutical products. It also evaluates the effects of public health safeguards provided in the Agreement on Trade Related Aspects of Intellectual Property Rights. The first chapter is based on theoretical grounds and it describes the relation between IPR, economics and law. The second chapter defines the international framework for IPR protection and the relation between IPR and developing countries. The third chapter provides information on what to avoid when creating IPR legislation and what to focus on. The final part constitutes of a case study. The subject of the case study is Nigeria and the aim is to characterize current developments in access to antiretrovirals (drugs used to fight HIV/AIDS), to describe the system of patent protection in this country and to outline possible solutions that would lead to improvement in procurement of HIV/AIDS treatment.
|
guest ::
